Jacobus Pharmaceutical Company Inc.
Jacobus Pharmaceutical Company Inc. appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0008-2022, Class I) was initiated on September 9, 2021.
Summary
- Total Recalls
- 1 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0008-2022 | Class I | Ruzurgi (amifampridine) Tablets 10 mg, packaged in 100-count bottles, Rx only, Manufactured by: Jaco | September 9, 2021 |